|
|
Home | Submit Press Release | Advertise | Submit Website
(CityRegions.Com, September 20, 2017 ) Cephalosporins are bactericidal antibiotics and act by inhibiting cell wall synthesis. They inhibit a wide variety of gram-positive and gram-negative bacteria. They are considered broad-spectrum antibiotics with similar activities to those of ampicillin. They are sometimes grouped into "generations" by their antimicrobial properties. Cephalosporin drugs can be grouped into five classes or generations. The gram-negative antimicrobial property significantly increases with each newer generation of cephalosporin.
Publisher's analysts forecast the global cephalosporin drugs market to grow at a CAGR of 3.21% over the period 2014-2019.
For more information http://www.reportsweb.com/global-cephalosporin-drugs-market-2015-2019
In this report, Publisher covers the present scenario and growth prospects of the global cephalosporin drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria.
Publisher's report, Global Cephalosporin Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cephalosporin drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
- Americas
- APAC
- EMEA
Key vendors
- Allergan
- Astellas
- Bristol-Myers Squibb
- GlaxoSmithKline
- Merck
- Pfizer
- Sandoz
- Teva Pharmaceuticals
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001232305/sample
Other prominent vendors
- Abbott
- Aspen Pharmacare
- AstraZeneca
- Aurobindo Pharma
- Basilea Pharmaceuticals
- Baxter
- Biocon
- Corden Pharma
- Cornerstone Therapeutics
- Eli Lilly
- F. Hoffmann-La Roche
- Flynn Pharma
- Hospira
- Incepta Pharmaceuticals
- Johnson & Johnson
- Kyorin Pharmaceutical
- Lupin Pharmaceuticals
- Orchid Pharma
- Par Pharmaceutical
- Pernix Therapeutics
- Sanofi
- Shionogi
- Sun Pharmaceutical
- Takeda Pharma
- Theravance Biopharma
- Wockhardt
Market driver
- Special regulatory designation for pipeline molecules
- For a full, detailed list, view our report
Market challenge
- Development of drug resistance
- For a full, detailed list, view our report
Market trend
- Use of combination therapies
- For a full, detailed list, view our report
Purchase Report at http://www.reportsweb.com/inquiry&RW0001232305/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
